Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Countries such as the UK, France, Poland, Sweden and Italy offer tremendous advantages for drug and device developers. But, conducting clinical trials in the EU can be challenging and unpredictable.
Now you can learn the inside story of how to successfully navigate development faster in the EU — without running into compliance problems or triggering costly delays.
CD and Transcript Only - July 29, 2010
You'll receive an audio CD and a written transcript of the entire Virtual Summit, including the Q&A period and all presentation materials, four weeks after the session.